← back to database
Fast Track Initiative backs seed and early-stage life sciences startups to advance therapeutics, diagnostics, digital health, and healthcare services. It operates in Japan and the US and provides hands-on support through strategy, partnerships, syndication, and talent recruitment. The firm leverages its extensive network with academia, industry partners, regulators, and investors to source and de-risk deals. It focuses on therapeutic platforms and broader healthcare innovation to accelerate global impact from Japan’s research ecosystem. The approach aims to expand access to life-saving medicines and improve patient outcomes worldwide.
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Hiromichi KimuraFounder and Representative Partner
- Tomohiro AnzaiRepresentative Partner